Cell therapy could replace need for kidney transplants

(Wake Forest Baptist Medical Center) Wake Forest Institute for Regenerative Medicine (WFIRM) scientists are working on a promising approach for treatment of chronic kidney disease - regeneration of damaged tissues using therapeutic cells.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

ConclusionThis is the first long-term follow-up study demonstrating that CKD progressing to the need for RRT can develop after TTTS. Donor-twin status and neonatal AKI associated with adverse long-term outcomes warranting long-term surveillance in this group.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
AbstractBackgroundAmong children who receive a kidney transplant, short stature is associated with a more complicated post-transplant course and increased mortality. Short stature prior to transplant may reflect the accumulated risk of multiple factors during chronic kidney disease (CKD); however, its relationship with post-transplant kidney function has not been well characterized.MethodsIn the Chronic Kidney Disease in Children (CKiD) cohort restricted to children who received a kidney transplant, short stature (i.e., growth failure) was defined  as age-sex-specific height 
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
Conclusion: Clinical presentations of UN are broad and non-specific; nonetheless, it is important to detect early changes in order to avoid its progression. The earlier UN is diagnosed and treated, the more successful are the clinical outcomes.RESUMO INTRODU ÇÃO: A neuropatia periférica (NU) é um distúrbio que afeta o corpo celular, o axônio ou a mielina do motor ou neurônios sensoriais periféricos e ocorre em 60%-100% dos pacientes que são submetidos à diálise por doença renal crônica. A neuropatia urêmica é atribuí...
Source: Revista da Associacao Medica Brasileira - Category: General Medicine Source Type: research
Conclusion: Clinical presentations of UN are broad and non-specific; nonetheless, it is important to detect early changes in order to avoid its progression. The earlier UN is diagnosed and treated, the more successful are the clinical outcomes.RESUMO INTRODU ÇÃO: A neuropatia periférica (NU) é um distúrbio que afeta o corpo celular, o axônio ou a mielina do motor ou neurônios sensoriais periféricos e ocorre em 60%-100% dos pacientes que são submetidos à diálise por doença renal crônica. A neuropatia urêmica é atribuí...
Source: Revista da Associacao Medica Brasileira - Category: General Medicine Source Type: research
Conclusion: Clinical presentations of UN are broad and non-specific; nonetheless, it is important to detect early changes in order to avoid its progression. The earlier UN is diagnosed and treated, the more successful are the clinical outcomes.RESUMO INTRODU ÇÃO: A neuropatia periférica (NU) é um distúrbio que afeta o corpo celular, o axônio ou a mielina do motor ou neurônios sensoriais periféricos e ocorre em 60%-100% dos pacientes que são submetidos à diálise por doença renal crônica. A neuropatia urêmica é atribuí...
Source: Revista da Associacao Medica Brasileira - Category: General Medicine Source Type: research
Conclusion: Clinical presentations of UN are broad and non-specific; nonetheless, it is important to detect early changes in order to avoid its progression. The earlier UN is diagnosed and treated, the more successful are the clinical outcomes.RESUMO INTRODU ÇÃO: A neuropatia periférica (NU) é um distúrbio que afeta o corpo celular, o axônio ou a mielina do motor ou neurônios sensoriais periféricos e ocorre em 60%-100% dos pacientes que são submetidos à diálise por doença renal crônica. A neuropatia urêmica é atribuí...
Source: Revista da Associacao Medica Brasileira - Category: General Medicine Source Type: research
Advanced kidney disease is often considered a relative contraindication to LVAD implantation and many implanting centers view stage 4 and 5 chronic kidney disease (CKD) as an absolute contraindication. We sought to analyze the impact of CKD at the time of LVAD implant on outcomes.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 572 Source Type: research
Acute Kidney Injury (AKI) is known to be associated with poor outcomes in patients undergoing Left ventricular assist device (LVAD) implantation. We sought to determine the trends and predictors of AKI in this patient population.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 571 Source Type: research
A retrospective multi-center cohort study was conducted, including all patients undergoing LVAD implantation. The Chronic Kidney Disease Epidemiology collaboration equation was used to determine the estimated glomerular filtration rate. Creatinine measurements were collected over a 2-year follow-up period. Patients stratification was based on their pre-operative CKD stage.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 563 Source Type: research
This study was conducted to determine the rate of AKI and CKD post LT and recovery of AKI while using IVFK.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 760 Source Type: research
More News: Chronic Kidney Disease | International Medicine & Public Health | Kidney Transplant | Kidney Transplantation | Transplants | Urology & Nephrology